The IFN-α therapy induces an MR on JAK2V617F PV patients according to the IFNL4 functional status: very high MR for N: no IFNL4 and S: IFNL4-S70 and less MR for P: IFNL4-P70.
The IFN-α therapy induces an MR on JAK2V617F PV patients according to the IFNL4 functional status: very high MR for N: no IFNL4 and S: IFNL4-S70 and less MR for P: IFNL4-P70.